Jacobus Pharmaceutical Company Inc.

FDA Regulatory Profile

Summary

Total Recalls
1 (1 Class I)
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0008-2022Class IRuzurgi (amifampridine) Tablets 10 mg, packaged in 100-count bottles, Rx only, Manufactured by: JacoSeptember 9, 2021